Physician profile
John Gary Phillips
NPI 1154648426
$23,280.82
in general payments reported to CMS, 2019-2025
13 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $395 · 2023: $14K · 2024: $7,294 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $2,419 · Travel and Lodging: $2,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,250.00 |
| Food and Beverage | $2,419.44 |
| Travel and Lodging | $2,098.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $17,594.11 | 2023-2025 | Neuroblate |
| Novartis Pharmaceuticals Corporation | $3,200.22 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $566.01 | 2023-2025 | Erleada, Pipeline, Akeega |
| Reflexion Medical, INC. | $523.58 | 2023 | Reflexion Medical Radiotherapy System |
| Astrazeneca Pharmaceuticals Lp | $378.41 | 2023-2025 | Lynparza |
| Siemens Medical Solutions USA, INC. | $221.98 | 2023-2025 | Varian Ethos Treatment Planning, Truebeam, Somatom Go.Top |
| Palette Life Sciences, INC. | $136.01 | 2022 | |
| Boston Scientific Corporation | $133.92 | 2022 | |
| Exelixis INC. | $130.00 | 2023 | Cabometyx |
| Brainlab, INC. | $125.42 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $117.83 | 2021 | |
| Dendreon Pharmaceuticals LLC | $101.81 | 2025 | Provenge |
| Janssen Biotech, INC. | $51.52 | 2024 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.